|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 413/14 | (2006.01) |
| C07D 417/14 | (2006.01) | ||
| C07D 413/04 | (2006.01) | ||
| A61K 31/422 | (2006.01) | ||
| A61K 31/428 | (2006.01) | ||
| A61P 31/20 | (2006.01) |
| (11) | Number of the document | 3441389 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17778663.9 |
| Date of filing the European patent application | 2017-04-06 | |
| (97) | Date of publication of the European application | 2019-02-13 |
| (45) | Date of publication and mention of the grant of the patent | 2021-09-08 |
| (46) | Date of publication of the claims translation | 2021-10-11 |
| (86) | Number | PCT/CN2017/079552 |
| Date | 2017-04-06 |
| (87) | Number | WO 2017/173999 |
| Date | 2017-10-12 |
| (30) | Number | Date | Country code |
| 201610210422 | 2016-04-06 | CN |
| (72) |
CHEN, Huanming , CN
|
| (73) |
Shanghai Zhimeng Biopharma, Inc. ,
Room A302, A304, Building 1,1976 Gaoke Middle Road
China (Shanghai) Pilot Free Trade Zone
Pudong New Area, Shanghai 201210,
CN
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Pirazol-oksazolidinono junginys prieš hepatito B virusą |
| PYRAZOLE-OXAZOLIDINONE COMPOUND FOR ANTI-HEPATITIS B VIRUS |
| Payment date | Validity (years) | Amount | |
| 2026-03-23 | 10 | 231.00 EUR |
| 2027-04-06 |